Sign In
Buy RHHBY
$51.57
+2.51 (+5.12%)
At Close: Jun 04, 2026
15 European Dividend Aristocrats to Diversify Your Portfolio
01:47pm, Wednesday, 21'st Jul 2021
Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out. The post 15 European Dividend Aristocrats to Diversify Your
AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic Syndromes
05:59am, Wednesday, 21'st Jul 2021
The FDA has granted Breakthrough Therapy Designation (BTD) to Venclexta (venetoclax) combined with azacitidine for the potential treatment of adult patients with myelodysplastic syndromes (MDS). Ven
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that Venclexta® (venetoclax) in combination with azacitidine has bee
Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19
01:00am, Tuesday, 20'th Jul 2021
Basel, 20 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve™(casirivimab and imdevimab), for the treatm
Roche Unveils New Hemlibra Data Reinforcing Safety Profile In Hemophilia A
08:18am, Monday, 19'th Jul 2021
According to Roche Holding AG's (OTC: RHHBY) Genentech division, new data from a phase 3b study reinforces the safety profile of blockbuster hemophilia A treatment Hemlibra. The new safety data f
New Data for Genentech's Hemlibra (emicizumab-kxwh) Reinforce Safety Profile in People With Hemophilia A
01:00am, Monday, 19'th Jul 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the final analysis of the Phase IIIb STASEY study, which
AVZ Minerals boosts Roche Dure lithium and tin ore reserves by 41.6%
11:38pm, Tuesday, 13'th Jul 2021
AVZ Minerals Ltd's (ASX:AVZ) (OTCMKTS:AZZVF) (FRA:3A2) recent ore reserve estimate has resulted in an increase of 41.6% at Roche Dure deposit of the Manono Lithium and Tin Project in the Democratic Re
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
02:04pm, Sunday, 11'th Jul 2021
Several drugmakers have important clinical trial updates on the way.
Basel, 09 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas® MTB and cobas® MTB-RIF/INH tests for use on the cobas® 6800/8800 Systems are included as part of the updated
WHO Guidelines Put Spotlight on Arthritis Drugs Actemra & Kevzara
12:02pm, Thursday, 08'th Jul 2021
The latest guideline update by the WHO includes the use of arthritis drugs like Roche's (RHHBY) Actemra and Sanofi's (SNY) Kevzara for the treatment of severe COVID-19.
WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients
11:47am, Wednesday, 07'th Jul 2021
The World Health Organization (WHO) has endorsed Interleukin-6 (IL-6) receptor antagonists combined with corticosteroids to treat severe COVID-19 cases. Patients severely or critically ill with COVI
WHO recommends Roche, Sanofi/Regeneron drugs as COVID-19 treatments, calls for lower prices
07:48am, Wednesday, 07'th Jul 2021
The World Health Organization began recommending the use of medicines called interleukin-6 receptor blockers as COVID-19 treatments for the severely ill, based on the findings of a large clinical stud
Veteran strategist David Roche explains why he thinks it's 'too risky' to own Chinese tech stocks
02:42am, Monday, 05'th Jul 2021
Roche said uncertainties are coming from an ongoing regulatory crackdown in China and the geopolitical rivalry between Washington and Beijing.
Basel, 02 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from its haemophilia A clinical programme will be presented at the virtual International Society on Thrombosis an
Roche to cut 300-400 product development jobs - Blick
06:23am, Thursday, 01'st Jul 2021
Roche plans to cut 300-400 jobs this year at product development (PD) sites, company executives including Chief Medical Officer Levi Garraway said during a recorded video call with employees obtained
